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Human LMNA genemutations result in laminopathies
that include Emery-Dreifuss muscular dystrophy
(AD-EDMD) and Hutchinson-Gilford progeria, the
premature aging syndrome (HGPS). The Lmna null
(Lmna/) and progeroid LmnaD9 mutant mice are
models for AD-EDMD and HGPS, respectively. Both
animals develop severe tissue pathologies with
abbreviated life spans. Like HGPS cells, Lmna/
and LmnaD9 fibroblasts have typically misshapen
nuclei. Unexpectedly, Lmna/ or LmnaD9 mice
that are also deficient for the inner nuclearmembrane
protein Sun1 showmarkedly reduced tissue patholo-
gies and enhanced longevity. Concordantly, reduc-
tion of SUN1 overaccumulation in LMNA mutant
fibroblasts and in cells derived from HGPS patients
corrected nuclear defects and cellular senescence.
Collectively, these findings implicate Sun1 protein
accumulation as a common pathogenic event in
Lmna/, LmnaD9, and HGPS disorders.INTRODUCTION
The nuclear lamina that underlies the inner nuclear membrane
(INM) is a meshwork of type-V intermediate filament proteins,
consisting primarily of A- and B-type lamins (Gu¨ttinger et al.,
2009).Mammalian somatic cells express fourmajor types of lam-
ins, including A and C encoded by Lmna (Burke and Stewart,
2006; Stuurman et al., 1998), and B1 and B2, each encoded by
their own genes (Lmnb1 and 2) (Shimi et al., 2008; Stuurman
et al., 1998). In addition to providing mechanical strength to the
nucleus, recent discoveries in nuclear-lamina-associated humandiseases have established intimate connections between the
nuclear envelope/lamina and processes such as gene expres-
sion, DNA repair, cell cycle progression, and chromatin organiza-
tion (Liu et al., 2005; Nagano and Arahata, 2000; Chi et al., 2009a;
Capell and Collins, 2006; Worman and Courvalin, 2004).
Some 28 diseases/anomalies (the nuclear envelopathies) are
linked to mutations in proteins of the nuclear envelope and
lamina, and about half the diseases arise from mutations in the
Lamin genes, predominately LMNA. These disease phenotypes
range from cardiac and skeletal myopathies, lipodystrophies,
and peripheral neuropathies to premature aging with early death
(Burke and Stewart, 2002, 2006; Burke et al., 2001; Chi et al.,
2009a; Worman and Courvalin, 2004). Two notable laminopa-
thies are the autosomal-dominant form of Emery-Dreifuss
muscular dystrophy (AD-EDMD), which results inmusclewasting
and cardiomyopathy, and Hutchinson-Gilford progeria
syndrome (HGPS), a rare genetic premature aging disease in
which affected individuals expirewith amean life spanof 13 years
(Kudlow et al., 2007). AD-EDMD is caused by missense muta-
tions and/or deletions throughout the LMNA gene that generally
disrupt the integrity of the lamina, resulting in mechanical weak-
ening of the nucleus andmaking itmore vulnerable tomechanical
stress. With HGPS, most cases arise from a single heterozygous
mutation at codon 1824 of LMNA. This mutation produces an in-
frame deletion of 50 amino acids and generates a truncated form
of LAD50 lamin A, termed progerin, which remains farnesylated
(De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003; Gold-
man et al., 2004). HGPS individuals are overtly normal at birth,
with the disease manifesting around 18 months (Merideth et al.,
2008). The current view is that the permanently farnesylated pro-
gerin is affixed to the nuclear membrane and results in a toxic
gain of function that elicits HGPS.How farnesylated progerin trig-
gers HGPS is not understood.
Lmna/mice (Sullivan et al., 1999) were developed and found
to model AD-EDMD. Subsequently, another mouse model wasCell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc. 565
created with homozygous LmnaL530P/L530P mutations in Lmna
(later termed LmnaD9 mice; Hernandez et al., 2010; Mounkes
et al., 2003) that expresses a deleted form of Lmna (deleted
for exon 9 with the inframe removal of 40 amino acids of lamin
A/C). There are distinct differences between Lmna/, LmnaD9,
and HGPS. The Lmna/ mouse does not express a full-length
lamin A protein, whereas the LmnaD9 mouse recapitulates
many HGPS-associated pathologies including early death, skel-
etal anomalies, and vascular smooth muscle defects (Mounkes
et al., 2003) and homozygously expresses a farnesylated lamin
A-DExon9 mutant protein that, though similar, is not identical
to the heterozygous expression of the LAD50 mutant protein in
HGPS. Nonetheless, Lmna/ and LmnaD9mice andHGPS indi-
viduals share three significant features. All have Lmnamutations,
significant dystrophic cellular, tissue and organ changes, and
markedly abbreviated life spans.
Currently, although aberrant LAD50 progerin expression is
implicated as causing HGPS, the full understanding of this and
other causal events for lamin A-associated pathology is elusive.
The lamins are proposed to interact with many INM proteins,
including Emerin, lamina-associated polypeptides (LAPs) and
MAN1, and the SUN domain proteins, SUN1 and SUN2 (Burke
and Stewart, 2002; Mattioli et al., 2011; Crisp et al., 2006; Os-
tlund et al., 2009). A detailed biochemical understanding of these
interactions is complicated by the relative insolubility of these
proteins. The SUNs are components of the LINC (links the nucle-
oskeleton and cytoskeleton) complex that connect the nuclear
lamina and envelope with the cytoskeleton (Crisp et al., 2006).
The LINC complex is important in nuclear positioning and cellular
migration in lower and higher eukaryotes (Malone et al., 1999).
How the inner nuclear membrane SUN proteins function with
lamins remains unclear, but currently there is no evidence that
they are involved in laminopathies (Haque et al., 2010). Here
we present evidence that Lmna/, LmnaD9, and HGPS
dysfunctions converge at a common pathogenic overaccumula-
tion of the inner nuclear envelope Sun1 protein. Accordingly, loss
of the Sun1 gene in Lmna/ and LmnaD9 mice extensively
rescues cellular, tissue, organ, and life span abnormalities. Simi-
larly, the knockdown of overaccumulated SUN1 protein in
primary HGPS cells corrected their nuclear defects and cellular
senescence. Our results reveal Sun1 overaccumulation as
a potentially pivotal pathologic effector of some laminopathies.
RESULTS
Loss of Sun1 Ameliorates Lmna/ and LmnaD9
Pathologies
To gain insight into the cooperativity, if any, between INM
proteins and the underlying lamina in disease development, we
bred Sun1+/ (Chi et al., 2009b) and Lmna+/ (Sullivan et al.,
1999) mice to produce Lmna/Sun1/ offspring. A priori, it
was anticipated that inactivating both Lmna and Sun1 in
Lmna/Sun1/mice would lead to a more severe pathological
phenotype than that seen for Lmna/ animals. Surprisingly, we
observed the opposite. In the Lmna/ context, the removal of
Sun1, rather than exacerbating pathology, unexpectedly amelio-
rated deficits in bodyweight (Figure 1A; p < 0.0001) and longevity
(Figure 1B; p < 0.01). This rescue of Lmna/ mice by loss of566 Cell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc.Sun1 was verified in a second laminopathy model, the LmnaD9
mutant mouse (Mounkes et al., 2003; Hernandez et al., 2010).
The body weight and longevity deficits in LmnaD9 mice were
also rescued in the LmnaD9Sun1/ counterparts (Figures 1C
and 1D). Remarkably, whereas all LmnaD9 mice expired by
30 days after birth, their LmnaD9Sun1/ littermates thrived
past this date, and most achieved life spans more than twice
this duration (Figure 1D). At the cellular level, the severely
reduced proliferation of Lmna/ and LmnaD9 fibroblasts was
also substantially corrected in Lmna/Sun1/ and
LmnaD9Sun1/ cells (Figures 1E and 1F).
Tissue Pathologies Are Improved in Sun1/Lmna/
Mice
Lmna/ and Lmna/Sun1/ animals grow to a greater size
and live longer than their corresponding LmnaD9 and
LmnaD9Sun1/ counterparts (Figures 1A–1D). Cultured
Lmna/ and Lmna/Sun1/ cells proliferated well, whereas
LmnaD9 and LmnaD9Sun1/ cells are challenging, requiring
extracellular matrices or hypoxic conditions for propagation
(Hernandez et al., 2010). For detailed characterizations, we
chose to study the Lmna/ and Lmna/Sun1/ animals and
their cells.
We compared tissue changes in Lmna/ to Lmna/Sun1/
mice. The spine of Lmna/mice by microcomputerized tomog-
raphy was grossly lordokyphotic; this defect was absent in
wild-type (WT) and Sun1/ mice and was corrected in
Lmna/Sun1/ animals (Figure 2A). The femoral bone of 40-
day-old Lmna/ mice showed trabecular and bone densities
that were notably sparser and thinner than in Sun1/ or WT
mice; in Lmna/Sun1/ animals, the deficits were markedly
improved (Figure 2B). In other tissues, such as cardiac and skel-
etal muscle, pathologies, previously described in the Lmna/
mice, were corrected and improved in the Lmna/Sun1/
mice (Figure S1 available online).
Sun1 Accumulates at the Nuclear Envelope and the
Golgi of Lmna/ MEFs
To seek amolecular explanation for loss-of-lamin A changes and
their correction by Sun1 depletion, we investigated Sun1 expres-
sion in lamin A WT and Lmna/ mouse embryonic fibroblasts
(MEFs). Sun1 and lamin A colocalize at the Nuclear Envelope
(NE) in WT MEFs (Figure 3A, left panels). In contrast, in Lmna/
MEFs, Sun1 is found in theNE and at increased levels in theGolgi
(Figure 3A, middle panels; Figure S2A) based on costaining with
Golgi marker GM130 (Figure S2A, right), but not with ER marker
calnexin (Figure S2A, left). NE localization and Golgi overaccu-
mulation of Sun1 were also seen in LmnaD9 mouse fibroblasts
(Figure S2A, right). That Sun1 localizes with Golgi constituents
in Lmna/ cells was supported by biochemical fractionation of
mouse tissues that detected Sun1 and GM130 in the same
sucrose density fractions (Figure S2B). When Lmna/ cells
were examined for the relative distribution of Sun1 in the NE
versus the Golgi, the amount in the latter increased proportion-
ally with its level in the former (Figure S2C), suggesting that
increased levels of Sun1 protein, in an Lmna/ context, first
occupy and saturate NE sites before ‘‘spilling’’ into the Golgi
compartment. The average Sun1 expression level in individual
Figure 1. Defects in Body Weight and Longevity in Lmna/ and LmnaD9 Mice Are Ameliorated in Homozygous Sun1 Knockout
Lmna/Sun1/ and LmnaD9Sun1/ Animals
(A) Body weights are averages from mice with the indicated genotypes. The number (n) of animals used is indicated.
(B) Kaplan-Meier graph showing increased life span of Lmna/Sun1/ compared to Lmna/ mice. Median survival of wild-type or Sun1/ is > 210 days in
a 7 month follow up; Lmna/ mice have median survival of 41 days; Lmna/Sun1+/ mice have a median survival of 54 days; Lmna/Sun1/ mice have
a median survival of 104 days (p < 0.01 comparing Lmna/ and Lmna/Sun1/.)
(C) Body weights of LmnaD9 mice that are wild-type, heterozygous, or homozygous for Sun1 deficiency. Wild-type and Sun1/ cohorts are graphed for
comparison. Values are averages ±SEM from animals in each cohort. Number (n) of animals is indicated. (p < 0.0001 comparing LmnaD9Sun1+/+ and
LmnaD9Sun1/.)
(D) Kaplan-Meier graph showing increased life span of LmnaD9Sun1/ compared to LmnaD9Sun1+/+ mice. LmnaD9Sun1+/mice are also graphed. (p < 0.0001
comparing LmnaD9Sun1+/+ and LmnaD9Sun1/.)
(E) Cell proliferation of the indicated MEFs. Curves are averages ±SD, representative of > 3 independent isolates from embryos of the indicated genotypes.
(F) Proliferation curves of MAFs (mouse adult fibroblasts) fromWT, Sun1/, LmnaD9Sun1+/+ and LmnaD9Sun1/mice. MAFs were seeded at a density of 1000
cells per well. Growth was measured, and normalized cell indexes (averages+/SD) are presented.Lmna/ MEFs was significantly higher than that in WT MEFs
(Figure 3B; Lmna/ n = 36, WT n = 29, p < 0.0001), and the high-
est expressing former cells had approximately 8-fold greaterlevels of Sun1 than the lowest expressing latter counterparts;
in contrast, in Lmna/ cells, other NE proteins such as Sun2
and Nup153 were unchanged in distribution or amounts,Cell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc. 567
Figure 2. Correction of the Lmna/ Skeletal
Defects in the Lmna/Sun1/ Double-Knockout
Mouse
(A) Micro-CT scans of the indicated mice. Lmna/ mice
display a lordokyphosis (curvature of the spine) phenotype
corrected in Lmna/Sun1/ mice.
(B) Three-dimensional micro-CT images of the femoral
trabeculae from 40-day-old mice (left). Thinner trabecular
formation was observed in the Lmna/mouse compared
to the other genotypes. Right panels quantify bone
density+/SD (upper) and the number of trabeculaes/
mm+/SD (lower). P values are shown. See also Fig-
ure S1.whereas Emerin and Nesprin1 were not significantly increased
but showed modest increases in ER relocalization (Figures
S2D and S2E). The increase in Sun1 protein (Figure S2E) was
not due to elevated Sun1 mRNA levels (compare WT and
Lmna/; Figure S2F). This result, together with heightened
Sun1 accumulation (Figure S3A) when WT and Lmna/ MEFs
were treated with proteasome inhibitor lactacystin and the pro-
longed half-life of Sun1 protein in Lmna/ versus WT MEFs
(Figure S3B), suggests that Sun1 overaccumulation in Lmna/
cells is due to reduced protein turnover.
Sun1 Overaccumulation Increases Nuclear Defects
WTMEFs have circular or slightly ovoid nuclei, whereas Lmna/
nuclei are irregularly shaped with frequent herniations and blebs
(Figure 3C) (Sullivan et al., 1999). Intriguingly, Lmna/ nuclear
abnormalities are significantly reduced (p < 0.0001) in
Lmna/Sun1/ cells (Figures 3C and 3D), suggesting that the
nuclear irregularities are not explained simply by loss of lamin
A, which is equally absent in Lmna/ and Lmna/Sun1/
cells. On the other hand, because both Lmna/ and LmnaD9
cells show Sun1 accumulation in the Golgi (Figure 3A and Fig-
ure S2A), this event could possibly account for the observed
pathologies. This view, if correct, provides a parsimonious
explanation for why Lmna/ and LmnaD9 diseases in mice
are alleviated when Sun1 levels are reduced (Figure 1).
The above reasoning predicts that deliberate Sun1 overex-
pression in an Lmna/ context should exacerbate nuclear
aberrancies. To test this, we transfected increasing amounts of568 Cell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc.a mouse Sun1 (mSun1) expression vector into
either Lmna/Sun1/ or WT MEFs. The over-
expression of Sun1 progressively increased the
prevalence of nuclear herniations in
Lmna/Sun1/ MEFs without significantly
affecting WT MEFs (Figure 3E). The transfec-
tions also elicited dose-dependent increases
in the apoptosis of Lmna/Sun1/ cells
(Figure 3F).
Golgi Targeting of Sun1 Elicits Nuclear
Herniations
A remarkable feature of Sun1 expression in
Lmna/ MEFs is its misaccumulation in the
extranuclear Golgi apparatus (Figure 3A andFigure S2A). Protein misaccumulation in human organelle
storage disorders has been described for lysosomal storage
diseases such as Fabry, Tay-Sachs, Gaucher, Niemann-Pick,
Pompe, and Krabbe (Metz et al., 2011) and for endoplasmic
reticulum storage diseases such as cystic fibrosis, a1-antitrypsin
deficiency, hereditary hypoparathyroidism, and procollagen
type I, II, and IV deficiency (Rutishauser and Spiess, 2002);
however, to date, there are no good examples of Golgi storage
diseases. To test whether the deliberate Golgi misaccumulation
of Sun1 is significantly pathogenic, we constructed an HA-
tagged Tgn38-fused Golgi-targeting mSun1 expression vector
(Tgn38 is an integral Golgi protein; see Szentpetery et al.
[2010]). Sun1 protein, when overexpressed in WT MEFs, local-
ized to the nuclear envelope and elicited barely discernable
mild nuclear blebbings (Figure 4A), whereas transfected
Tgn38-Golgi-targeted mSun1 dramatically increased Golgi
accumulation and nuclear herniations with obvious cytoplasmic
accumulation of lamin B1 (Figure 4B) in 83% of Tgn38-Golgi-
mSun1 expressing cells (Figure 4C). Recently, it was reported
that the Sun1-related Sun2 protein has a Golgi retrieval signal,
ensuring its transport from the Golgi back to the ER (Turgay
et al., 2010). Although not yet determined, Sun1 may differ in
the Golgi retrieval signal, which could explain why a SUN1
mutant (human SUN1 [aa] 103–785) (Figure S4; Haque et al.,
2010; Chi et al., 2007) and a wild-type Sun1 protein that is ex-
pressed in the absence of cell endogenous lamin A (i.e., Lmna/
cells; Figures 3A and S2A) are both found in the Golgi. We also
checked whether the Golgi-localizing SUN1 (103–785) mutant
Figure 3. Extranuclear Sun1 Is Accumulated in the Golgi of Lmna/ MEFs
(A) Cells were immunostainedwith lamin A (green) and Sun1 (red) antibodies. Extranuclear Golgi localization of Sun1 is seen in Lmna/MEFs. See also Figure S2.
(B) Quantification of Sun1 in MEFs. Mean ± SD reflects collective results from two separate experiments with n = 29 (WT) and n = 36 (Lmna/) MEFs. Difference
between WT and Lmna/ is statistically significant (p < 0.0001). See also Figure S3.
(C) WT, Lmna/, and Lmna/Sun1/ MEFs were stained with anti-Lamin B1 (red) and DAPI (blue). Lamin B1 nuclear envelope staining is intact in WT
and Lmna/Sun1/ MEFs, with the staining being irregular with herniations in Lmna/ nuclei. Arrows point to disruptions in nuclear envelope. Scale bars,
10 mm.
(D) Quantification of prevalence of cells with nuclear envelope disruptions. Values are averages +/SD from three independently isolated MEFs of the indicated
genotype (each counted for 300 nuclei). Prevalence of nuclear disruptions between Lmna/ and Lmna/Sun1/ MEFs is significantly different (p < 0.0001).
(E) Sun1 overexpression in the absence of lamin A exacerbates nuclear herniations (upper). WT and Lmna/Sun1/ MEFs were transfected with increasing
mouse Sun1 (mSun1) expression vector. Nuclei were stained 48 hr later. Values are averages +/SD from three experiments (each sample was counted for
300 nuclei per experiment). (Lower) Transfected cells were western blotted for Sun1 expression and actin (as loading control).
(F) WT (top) or Lmna/Sun1/ (bottom) MEFs were transfected with vector-alone (left) or increasing amounts of mSun1 (right three panels) and analyzed 48 hr
later by FACS for propidium iodide (PI; y axis) and annexin V (x axis). Percentage of apoptotic cells (in the lower right quadrant) is indicated.elicits nuclear aberrations. Indeed, overexpression of the SUN1
(103-785) mutant increased nuclear envelope rupture and cyto-
plasmic redistribution of lamin B1 (Figure S4).
The above results suggest that reducing Sun1 accumulation
in the Golgi might moderate Lmna/ nuclear irregularities. Bre-feldin A (BFA) is an antibiotic that reversibly interferes with the
anterograde transport of macromolecules from the endoplasmic
reticulum (ER) to the Golgi (Marie et al., 2008). We asked
whether BFA treatment of Lmna/ cells would reduce Sun1 in
the Golgi. Confocal imaging of Lmna/ MEFs treated withCell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc. 569
Figure 4. Overexpression of Golgi-Targeted Sun1
Increased Nuclear Aberrations and Cell Death
(A) WT MEFs were transfected with FLAG-tagged mouse
Sun1 vector and stained with mouse anti-FLAG (green),
rabbit anti-GM130 (red), and goat anti-lamin B1
(grayscale). A representative image of modest nuclear
blebs and ruffles seen in some transfected cells is shown.
Scale bars, 10 mm.
(B) A Golgi-targeted mouse Sun1 (fused with Tgn38, HA-
tagged) expression plasmid was transfected into WT
MEFs. Thirty hours later, cells were stained with mouse
anti-HA (green), rabbit anti-GM130 (red), and goat anti-
lamin B1 (grayscale). Aberrancies were visualized by
cytoplasmic lamin B1 staining (see arrowheads) of
pmSun1-Tgn38-HA transfected cells. Scale bars, 10 mm.
(C) Quantification of the cytoplasmic release of lamin B1 in
MEFs transfected (for 30 hr) with either mSun1 (mSun1-
FLAG) or the Golgi-targeted mSun1 (pmSun1-Tgn38-HA).
One hundred cells were counted in each case. See also
Figure S4.BFA at 10 mg/ml for 24 hr showed a reduction in most, albeit not
all, Golgi-trafficked Sun1 and GM130 proteins (Figure 5A, left)
with statistically significant (p < 0.001; p < 0.01) reduction in
nuclear aberrations in cells passaged four (P4) to eight (P8) times
in culture (Figure 5A, right graph).We also treated Lmna/MEFs
with nocodazole to block microtubule organization (Figure 5B) or
latrunculin B to interrupt actin assembly (Figure 5C). Nocodazole
disrupts the Golgi apparatus (Thyberg and Moskalewski, 1999),570 Cell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc.and its treatment of Lmna/ MEFs led to
a punctated redistribution of otherwise Golgi-
associated Sun1 and GM130 (Figure 5B). This
treatment also led to a moderate, but statisti-
cally significant, reduction of nuclear aberra-
tions (Figure 5B, right graph). In contrast,
latrunculin B did not affect Sun1 distribution in
the Golgi or ameliorate nuclear defects (Fig-
ure 5C). Collectively, the findings demonstrate
that endogenous (Figure 5) or exogenous (Fig-
ures 4 and S4) Sun1 misaccumulation in the
Golgi elicits substantial cellular pathologies,
and that reducing Sun1 Golgi accumulation
restores cellular normalcy.
SUN1 Overaccumulation in HGPS Cells
Correlates with Dysfunction
Wenext investigated SUN1 expression in HGPS
cells, querying whether (and how) this protein
might contribute to pathology. We immuno-
stained SUN1 expression in human skin fibro-
blasts from seven independent HGPS (LMNA
c.1824C>T [G608G]) (Figure S5A and Table
S1) and four normal individuals and verified
LAD50 progerin expression (Goldman et al.,
2004) in HGPS, but not in normal, cells (Fig-
ure S5B). By immunofluorescence, brighter
SUN1 staining was observed in HGPS cells
compared to control cells (representative exam-ples are in Figure 6A and Figure S5A; normal versus HGPS),
which is consistent with increased SUN1 expression by western
blotting (Figure S5B) and with an earlier report of SUN1 accumu-
lation in HGPS cells (Haque et al., 2010). Of note, our stainings
showed that not every HGPS cell had elevated SUN1, but that
cells that stained brightest for SUN1 were also ones that had
larger nuclei and more severe nuclear morphological distor-
tions (compare dim-SUN1 HGPS cells, white arrowheads to
Figure 5. Brefeldin A and Nocodazole, but Not Latrunculin, Treatment Reduced Nuclear Irregularities in Lmna/ MEFs
(A) (Left) Staining of Sun1 (red) and GM130 (green) in Lmna/ MEFs treated for 24 hr with brefeldin A (BFA; 10 mg/ml); note the reduction of Sun1 and GM130
from the Golgi. (Right) Quantification of BFA treatment on the nuclear morphology of Lmna/ MEFs. Untreated and treated cells were stained with mouse
Sun1-specific antibody or DAPI in cells passaged 4 (P4), and 8 (P8) times, respectively. The nuclear morphologywas evaluated by observers blinded for genotype
and by computerized image analyses. Nuclear irregularities are also seen in HGPS cells (see list in Table S1).
(B) (Left) Subcellular localization of Sun1 in Lmna/ MEFs untreated or treated with 5 mM nocodazole for 4 hr. The Golgi complex was stained with mouse
antibody against GM130 (green) and rabbit antibody against mouse Sun1 (red). (Middle) Cells untreated and treated with nocodazole and stained for a-tubulin
are shown. (Right) Quantification of nocodazole treatment on the nuclear morphology of Lmna/ MEFs. Difference between untreated and treated cells is
p = 0.0058.
(C) (Left) Lmna/ MEFs were untreated or treated with 40 nM of latrunculin (LAT-B) for 12 hr. Cells were fixed and stained for Sun1 and GM130. (Middle) Cells
untreated and treated with latrunculin and visualized with fluorescent phalloidin for actin are shown. (Right) Quantification of LAT-B treatment on the nuclear
morphology of Lmna/ MEFs. Difference between untreated and treated cells was statistically insignificant (p = 0.8376). All values are mean +/SD.bright-SUN1 HGPS cells, yellow arrowheads; Figure 6A). SUN1
mRNA levels did not differ significantly in HGPS versus normal
cells (Figure S5C), supporting the interpretation that reduced
protein turnover (Figure S3B), not increased transcription, under-
lies SUN1 accumulation.
To address whether elevated SUN1 levels in HGPS result in
pathologies, we asked whether knocking down SUN1 alleviates
nuclear defects. SUN1-specific or control siRNAs were trans-
fected into HGPS or normal skin fibroblasts, and nuclear appear-
ance was monitored (Figure S5D). The nuclear morphologies
were unchanged in cells treated with control siRNA (Figures 6B
and S5E), but SUN1-specific siRNA reduced the prevalence of
bright-SUN1 HGPS cells (compare AG11498 upper to lowerrow, Figures 6B and 6C) and lowered the number of cells with
aberrant nuclei (Figures 6B, 6D, and S5E; Table S1). The contri-
bution of SUN1 to nuclear morphology was assessed conversely
by deliberately overexpressing exogenous SUN1. Ectopic SUN1
overexpression in HGPS and normal fibroblasts significantly
increased aberrant nuclei (Figure 6E).
SUN1 Expression Correlates with HGPS
Heterochromatin Profile and Cellular Senescence
Chromatin disorganization and massive heterochromatin loss
are correlated with nuclear shape alterations in HGPS cells (Shu-
maker et al., 2006; Goldman et al., 2004). Assays for HGPS
heterochromatin loss have included markers such as the laminCell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc. 571
Figure 6. Nuclear Irregularities in HGPS Fibroblasts Correlate with SUN1 Expression
(A) SUN1 and lamin B1 in normal (AG03512 and AG03258) and HGPS (AG06297 and AG11498) skin fibroblasts are stained with anti-human SUN1 (green) and
anti-lamin B1 (red). DAPI is in blue. Yellow arrowheads point to cells expressing high SUN1, white arrowheads to cells with low SUN1.
(B) Nuclear morphologies and SUN1 staining of control (AG03512) and HGPS (AG11498) skin fibroblasts transfected with control or SUN1 siRNA for 72 hr.
(C) Quantification of SUN1 immunofluorescent intensities in cells treated with control or SUN1 siRNA. One hundred twenty to two hundred cells from each of the
indicated samples were visualized and quantified for staining intensities. The intensities were normalized to the SUN1 intensity in AG03512 cells. Cells with SUN1
572 Cell 149, 565–577, April 27, 2012 ª2012 Elsevier Inc.
A-associated NURD (nucleosome remodeling and deacetylase)
component RBBP4 (Pegoraro et al., 2009) and the pan hetero-
chromatin marker histone H3K9me3 (Shumaker et al., 2006;
Scaffidi and Misteli, 2005). To corroborate the nuclear
morphology findings (Figure 6), we investigated how SUN1
expression correlates with previously described HGPS hetero-
chromatin changes. When HGPS or normal-skin fibroblasts
were stained for RBBP4 (Figure 7A, left) or H3K9me3 (Figure 7A,
right), an inverse correlation was observed between the expres-
sion of SUN1andRBBP4 (Figure 7B, left) or H3K9me3 (Figure 7B,
right). In agreement with the results in Figure 6A, only a subset of
HGPS cells was bright SUN1 (yellow arrows = bright-SUN1,
white arrows = dim-SUN1; Figure 7A); interestingly, the bright-
SUN1 cells were also those with the larger, more distorted nuclei
as well as sparse staining for RBBP4 (Figures 7A and 7B, left) or
H3K9me3 (Figures 7A and 7B, right). Separately, we found that
RBBP4 expression was substantially reduced in 70% of
Lmna/ MEFs (Figure S6A) and in Lmna/ mouse liver tissue
(Figure S6B), further supporting an inverse relationship between
Sun1 and NURD activity.
We next asked whether knockdown of SUN1 would reverse
HGPS-associated heterochromatin changes. We compared
control-RNAi and SUN1-RNAi transfected HGPS cells and found
that the latter did recover RBBP4 expression relative to the
former (Figure 7C). Because heterochromatin dysregulation is
correlated with cellular senescence (Di Micco et al., 2011) and
because HGPS cells senesce prematurely (DeBusk, 1972;
Eriksson et al., 2003), we queried how SUN1 affects HGPS
senescence by knocking down SUN1 for 96 hr and examining
acidic senescence-associated b-galactosidase (SA-b-Gal) in
control and HGPS cells (Figure 7D). In normal cells, the extent
of senescence was similar (9%) between control-siRNA and
SUN1-siRNA samples (Figure 7D); however, in HGPS cells, the
observed high level of ambient senescence (22%), as
measured by b-galactosidase, was dramatically decreased (to
6%) after SUN1 knockdown. Moreover, HGPS fibroblasts,
when treated with SUN1-RNAi, gained a proliferative advantage
over control-RNAi treated cells (Figure 7E). These data collec-
tively support the interpretation that increasing SUN1 accumula-
tion is associated with HGPS pathology and removing overex-
pressed SUN1 and restores normal cellular physiology.
DISCUSSION
Here, we show that aberrant Sun1 expression is a critical patho-
genic event common to Lmna/, LmnaD9, and HGPS disor-
ders. As noted here and elsewhere, Lmna/ mice (Sullivan
et al., 1999), LmnaD9 mice (Hernandez et al., 2010; Mounkes
et al., 2003), and HGPS individuals (Merideth et al., 2008) share
a constellation of disorders that include nuclear aberrations,
dystrophic organ and tissue abnormalities, and abbreviated lifeintensities less than 2-fold different from average are represented by blue ba
stained >5-fold above average are represented by brown bar. *p < 0.001 when c
(D) Quantification of the prevalence of cells from (B) with nuclear irregularities.
SUN1-RNAi (Fisher’s exact test). See also Figure S5.
(E) Aberrant nuclear morphology in normal and HGPS fibroblasts transfected
transfected cells per sample and fifty transfected cells per sample were scored.spans. A current view is that progerin is causal of the LAD50
HGPS disease (Burtner and Kennedy, 2010; Liu et al., 2005;
Scaffidi and Misteli, 2005; Goldman et al., 2004). How progerin
mechanistically signals cellular and tissue damage remains
elusive. That said, the existence of the dystrophic and cardio-
myopathic pathologies in Lmna/ mice and multiple examples
of Lmna mutations (Novelli et al., 2002; Plasilova et al., 2004;
Sullivan et al., 1999) that do not synthesize progerin but do
produce degenerative-dystrophic diseases such as Emery-Drei-
fuss muscular dystrophy (Bonne et al., 1999), Charcot-Marie-
Tooth (De Sandre-Giovannoli et al., 2002; Chaouch et al.,
2003), Mandibuloacral dysplasia (Novelli et al., 2002), Dunni-
gan-type familial partial lipdystrophy (Cao and Hegele, 2000),
atypical Werner’s syndrome (Chen et al., 2003), and limb girdle
muscular dystrophy (Muchir et al., 2000; Kitaguchi et al., 2001),
require an understanding of progerin-independent and depen-
dent factors/cofactors underlying the pathologies.
The Sun1 protein connects the nucleoplasmwith the cytoskel-
eton (Crisp et al., 2006) and has roles in nuclear anchorage,
nuclear migration, and cell polarity. Deficits in Sun1 correlate
with developmental retardation in neurogenesis, gametogen-
esis, myogenesis, and retinogenesis (Ding et al., 2007; Lei
et al., 2009; Zhang et al., 2009; Yu et al., 2011; Chi et al.,
2009b). To date, how an inner nuclear envelope protein like
Sun1 fits into the pathogenesis of laminopathies is unknown
(Stewart et al., 2007).
The major unexpected finding here is that whereas Lmna/
mice and LmnaD9 mice thrive poorly and die prematurely,
the removal of Sun1, creating Lmna/Sun1/ and
LmnaD9Sun1/ mice, rescued pathologies and dramatically
improved longevity (Figures 1 and 2). To better understand these
results, we observed that at the cellular level, Lmna/ and
LmnaD9 fibroblasts have uniformly increased Sun1 expression
with significant protein misaccumulation in the Golgi (Figure 3A
and Figure S2). Furthermore, approximately one in three
LAD50 HGPS fibroblasts (Figures 6, 7, and S5; Table S1) was
elevated for SUN1 expression with the bright (high)-SUN1, but
not the dim (low)-SUN1, cells, exhibiting abnormal nuclear size
and shape, heterochromatin RBBP4 and H3K9me3 markers,
and cellular senescence (Figures 6 and 7). Even though one
cannot do a SUN1 knockout experiment in LAD50 HGPS individ-
uals, the knockdown of SUN1 in LAD50 HGPS cells considerably
improved nuclear size and/or shape defects, heterochromatin
loss, and cellular senescence (Figures 6 and 7). Thus, although
the approaches (knockout and knockdown) and disease
models (Lmna/, LmnaD9, and LAD50 HGPS) are not identical,
a parsimonious interpretation consistent with the collective
results is that Sun1 overaccumulation represents a common
effector of Lmna/, LmnaD9, and LAD50 HGPS pathologies.
How does Sun1 overaccumulate in Lmna/, LmnaD9, and
LAD50 HGPS cells? Sun1 is normally located in the NE,r; cells that are >2-fold, but <5fold are represented by pink bar; cells that
ompared to AG03512 cells (t test).
z, p < 0.0001, when comparing the same cells treated with control RNAi or
with an HA-tagged human SUN1 expression plasmid. Two hundred mock
P values, Fisher’s exact test.
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Figure 7. Knockdown of SUN1 Alleviated HGPS-Associated Loss of NURD Complex and Cellular Senescence
(A) Normal (AG03512) and HGPS (AG11498) skin fibroblasts were stained for heterochromatin markers (RBBP4 or H3K9me3; green) and SUN1 (red). Yellow
arrowheads point to high-SUN1 cells; white arrowheads denote low-SUN1 cells. See also Figure S6.
(B) Expression levels of RBBP4 or H3K9me3 and SUN1 in two normal and three HGPS skin fibroblasts were quantified by MetaMorph software. Each dot
represents fluorescence intensity (in Log10 scale) in a single cell of RBBP4 (left) or H3K9me3 (right) versus SUN1. Linear curve fitting and correlation coefficient (r)
are indicated. In HGPS cells, RBBP4 and H3K9me3 expression correlates negatively with SUN1 expression.
(C) HGPS fibroblasts (AG03513) treated with control or SUN1 siRNA for 72 hr were stained with antibodies for SUN1 (red) and RBBP4 (green). Increased RBBP4
expression was observed in SUN1 siRNA-treated cells compared to control siRNA-treated cells. Graphic quantification of the staining intensities of RBBP4
versus SUN1 in individual HGPS fibroblasts treated with control (blue) or SUN1 (brown) siRNA is shown (right); each dot represents a single cell (154 control and
157 SUN1 RNAi treated cells were quantified).
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positioned bymechanisms that are still obscure but may depend
on interaction with lamin A filaments underlying the nuclear
matrix (Haque et al., 2006; Mattioli et al., 2011; Ostlund et al.,
2009). As noted above, a SUN1 protein deleted in its N-terminal
(100 amino acids) lamin A-interacting domain relocates from
the NE to the Golgi (Figure S4; Haque et al., 2010; Chi et al.,
2007). Emerging evidence suggests that the SUN1-related
SUN2 protein has a Golgi retrieval sequence (Turgay et al.,
2010) that is required for retrieval of SUN2 from the Golgi to
the ER. Differences between the two proteins may explain why
Sun1, but not Sun2, expressed in the absence of cell endoge-
nous lamin A (i.e., Lmna/ cells; Figure 3 and Figure S2), accu-
mulates in the Golgi. Our findings show that Sun1 accumulation
arises from reduced protein turnover (Figure S3) and not
increased transcription (Figures S2F and S5C), suggesting that
approaches to enhance protein degradation might be therapeu-
tically beneficial (Cao et al., 2011).
We did not discern obvious Golgi overaccumulation of endog-
enous SUN1 in LAD50 HGPS cells. Although the explanation
for this remains unclear, it could be that Golgi overaccumulation
of SUN1 in human cells is highly toxic and selects rapidly against
the viability of cultured HGPS cells, or that the heterozygous
expression of wild-type lamin A in LAD50 HGPS cells is sufficient
to locate endogenous SUN1 to the NE, preventing overt Golgi
misaccumulation. Relevant to the former explanation, we
observed that early-passage Lmna/ MEFs show more
dramatic Sun1-Golgi misaccumulation than late-passage
counterparts, consistent with selection against cells with high
Sun1-Golgi misaccumulation.
What might be the consequences of Sun1 mislocation in
the Golgi? Our Golgi-targeting experiments with mSun1-Tgn38
(Figure 4) and SUN1 (103–785) mutant protein (Figure S4)
showed that Golgi storage of Sun1 is cytotoxic. This toxicity
may be akin to that elicited in abnormal human lysosomal
(Metz et al., 2011) or ER storage (Rutishauser and Spiess,
2002) diseases. Aside from organelle storage disorders, other
types of protein aggregation maladies like Alzheimer’s (Gouras
et al., 2010) exist. In Alzheimer’s disease, evidence now sug-
gests that it is the small, soluble amyloid-b oligomers, not the
large, easily visualized amyloid-b fibrils/plaques, that produce
neurotoxicity (Crews and Masliah, 2010). As mentioned above,
we currently do not exclude that Golgi accumulation of SUN1
may indeed occur in LAD50 HGPS cells in vivo and that such
cells may have rapidly succumbed and therefore are not repre-
sented in the mostly late-passage repository-deposited HGPS
fibroblasts (Table S1). However, like soluble amyloid-b oligo-
mers, which need not present as gross aggregates to be cyto-
toxic, it may be that the degree of SUN1 overexpression in
LAD50 HGPS cells (Figure 6E) is sufficient to functionally trigger
pathology without having to reach levels required for overt Golgi(D) Visualization (left) and quantification (right) of acidic senescence associate
passage 8) fibroblasts transfected with control or SUN1 RNAi for 96 hr. Standard
each experiment. Cell scoring was performed in a blinded fashion by an indepen
(E) Cell proliferation in normal (AG03257) and HGPS (AG11498) cells transfect
When cells reached confluency, equal numbers were seeded into dishes and
(day 0) and after another 4, 8, 10, and 12 days. Relative absorbance at 460
day N]/[(Absorbance460nm-background Absorbance460nm) at day 0]. Standard despillage. In LAD50 HGPS cells, increased SUN1 accumulation in
the nuclear envelope may sufficiently create dysfunction by
rendering a more rigid meshwork.
Progerin underlies LAD50 HGPS disease development (Eriks-
son et al., 2003; Scaffidi andMisteli, 2005; Goldman et al., 2004).
How does SUN1 fit into the picture where progerin synthesis is
the initial event inciting cellular dysfunction? In primary LAD50
HGPS cells or LmnaD9 mice where progerin (Figure S5B) or
lamin A-DExon9 protein is expressed, Sun1 knockdown is suffi-
cient to remedy cellular aberrancies and also senescence and
longevity defects (Figures 1, 6, and 7). A cogent interpretation
of these results is that SUN1 accumulation is positioned down-
stream of progerin or lamin A-DExon9, such that the depletion
of SUN1 sufficiently interrupts pathologic signaling. In Lmna/
mice, in which no progerin protein is synthesized, our data
show that Sun1 accumulation remains an important trigger of
loss-of-lamin A pathology. Future experiments are needed to
clarify, in noncodon 1824 (i.e., non LAD50) forms of HGPS (Pla-
silova et al., 2004) and in the many rare dystrophic human
diseases (Burke et al., 2001; Chi et al., 2009a; Capell and Collins,
2006; Kudlow et al., 2007) where no gain-of-function progerin-
like protein is synthesized, whether SUN1 (or other nuclear
envelope protein) misaccumulation is similarly important to
pathogenesis. Our current findings do suggest that at least in
the Lmna/, LmnaD9, and LAD50 HGPS diseases, Sun1 over-
accumulation is critical to pathologies. If this notion can be
broadly applied, it suggests that future clinical trials and thera-
pies for laminopathies that treat disease upstream events (i.e.,
targeting progerin) without resolving the downstream patho-
genic events (i.e., Sun1 misaccumulation) may be ineffective.EXPERIMENTAL PROCEDURES
Animals
Knockout mice were created using standard procedures. Because Sun1/
and Lmna/ mice are reproductively defective (Ding et al., 2007; Alsheimer
et al., 2004; Chi et al., 2009b), Sun1+/ mice were crossed with Lmna+/
mice to generate Lmna/Sun1/ mice, or Sun1+/ mice were crossed with
LmnaL530P/+ mice (Mounkes et al., 2003) to generate LmnaD9Sun1/ mice.
Lmna mutant lines are available from Jax Labs and LmnaD9 mice from
C.L. Stewart. Mouse genotypes were verified by PCR. All animal experiments
were conducted according to animal study protocols approved by the National
Institutes of Health (NIH) or the Singapore Animal Use Committee.
Immunofluorescence and Confocal Microscopy
Cells, fixed in 4% paraformaldehyde in PBS for 30 min and permeabilized with
0.1% Triton X-100 for 5 min at room temperatures, were incubated with 1%
BSA in PBS for 30 min to block nonspecific binding. Antibodies were diluted
at 1:100 to 1:1,000 and incubated for 1.5 hr at room temperature. After three
washes with PBS, cells were probed with fluorescent (Alexa-488, Alexa-594,
or Alexa-647)-conjugated secondary antibodies. Nuclei were counterstained
with Hoechst33342 or DAPI (Invitrogen), and Sun1 intensity was visualizedd b-galactosidase (SA-b-Gal) in normal (AG03257) and HGPS (AG11498 at
deviations are from three independent assays counting 1200 to 2000 cells in
dent investigator. P value (Chi-square) is indicated.
ed with control or SUN1 RNAi. Cells at 50% confluency were transfected.
quantified for proliferation using Cell Counting Kit-8 24 hr after cell seeding
nm was obtained by [(Absorbance460nm-background Absorbance460nm) at
viations are from triplicate experiments.
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using a Leica TCS SP5 microscope and quantified by the ImageJ 1.42q (NIH)
or MetaMorph (Molecular Devices) software. Other procedures are in
Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and one table and can be found with this article online at
doi:10.1016/j.cell.2012.01.059.
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